Bone Biopsy Market Research Report - Global Forecast till 2027

Global Bone Biopsy Market Research Report: Information by Type (Needle Biopsy and Open Biopsy), Guidance (MRI Guided and CT Guided), and End Users (Hospitals and Clinics, Surgical Centers, and Others), and Region (Americas, Europe, Asia-Pacific, Middle East & Africa)— Forecast till 2027

ID: MRFR/MED/3898-HCR | | Region: Global | 110 pages

Market Scenario

The global bone biopsy market is expected to register ~4.5% CAGR during the forecast period of 2019 to 2025 and is expected to reach USD 718 million by 2025. Bone biopsy is a procedure, in which a sample of cells or tissues are collected from the bone for examination. The procedure is generally performed to confirm the presence of bone cancer, investigation of a lesion, and identify the cause of inflammation or infection. Furthermore, factors such as stringent regulatory policies, product recall, and others are hampering the growth of the market.  

Segmentation

The global bone biopsy market is segmented on type, guidance, end users, and region. The global market for bone biopsy, by type, is segmented into needle biopsy and open biopsy. Based on guidance, the global market is divided into guided and non-guided, where the guided segment is further sub-segmented into MRI-guided and CT-guided. The guided segment is expected to hold the highest market share due to the clinical advantages over its non-guided counterparts. The end user segment consists of hospitals & clinics, specialty centers, and others. The hospitals & clinics segment is expected to dominate the market due to the increasing number of hospitals. In the current scope of the study, the segments mentioned above are covered under four regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The bone biopsy market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European bone biopsy market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The bone biopsy market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The bone biopsy market in the Middle East & Africa has been segmented into the Middle East and Africa.  

Key Players

Some of the key players operating in the global bone biopsy market are BD (US), B. Braun Melsungen AG (Germany), Cook (US), GENERAL ELECTRIC COMPANY (US), ARGON MEDICAL (US), MERMAID MEDICAL A/S (Denmark), Ranfac Corp. (US), Kimal (UK), and Remington Medical (US).  

Regional Market Summary Global Bone Biopsy Market Share (%), by Region, 2018 Sources: MRFR Analysis   The Americas dominated the bone biopsy market owing to the high prevalence of bone cancer and presence of major manufacturers in the region. In 2018, Europe accounted for the second-largest market share. However, Asia-Pacific is expected to register the fastest CAGR due to increasing awareness regarding bone cancer and growing healthcare infrastructure. On the other hand, the Middle East & Africa is expected to hold the least share in the bone biopsy market due to limited access to health facilities and lack of awareness regarding health management.

Global Bone Biopsy Market, by Type


  • Needle Biopsy

  • Open Biopsy


Global Bone Biopsy Market, by Guidance

  • GuidedMRI-Guided

  • CT-Guided

  • Non-Guided


Global Bone Biopsy Market, by End User

  • Hospitals and Clinics

  • Surgical Centers

  • Others


Global Bone Biopsy Market, by Region

  • Americas

    • North America

    • US

    • Canada





  • Europe

    • Western Europe

    • Germany

    • France

    • Italy

    • Spain

    • UK

    • Rest of Western Europe

    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience

  • Medical device manufacturers

  • Government research institutes

  • Academic institutes and universities

  • Venture capitalists



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 718 million (2025)
  CAGR   4.5% (2020-2027)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   type, guidance, end users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   BD (US), B. Braun Melsungen AG (Germany), Cook (US), GENERAL ELECTRIC COMPANY (US), ARGON MEDICAL (US), MERMAID MEDICAL A/S (Denmark), Ranfac Corp. (US), Kimal (UK), and Remington Medical (US).
  Key Market Opportunities

  • stringent regulatory policies
  • product recall
  •   Key Market Drivers   high prevalence of bone cancer


    Frequently Asked Questions (FAQ) :


    Global bone biopsy market is expected to expand at 4.5% CAGR from 2019 to 2025.

    Global bone biopsy market can touch USD 718 million by 2025.

    Rising prevalence of bone cancer is the primary driver of the global bone biopsy market.

    Recall of products and strict regulatory policies are factors expected to impede the global gastric bypass market growth.

    The Americas is expected to dominate in the global bone biopsy market till 2023 due to high prevalence of bone cancer.

    GENERAL ELECTRIC COMPANY, Cook, Kimal, Remington Medical, ARGON MEDICAL, BD, B. Braun Melsungen AG, Ranfac Corp., and MERMAID MEDICAL A/S are prominent players of the global bone biopsy market.

    Table Of Contents

    1. REPORT PROLOGUE

    2. MARKET INTRODUCTION

    2.1. Definition

    2.2. Scope Of The Study

    2.2.1. Research Objective

    2.2.2. Assumptions

    2.2.3. Limitations

    3. RESEARCH METHODOLOGY

    3.1. Overview

    3.2. Primary Research

    3.3. Secondary Research

    3.4. Market Size Estimation

    4. MARKET DYNAMICS

    4.1. Overview

    4.2. Drivers

    4.3. Restraints

    4.4. Opportunities

    5. MARKET FACTOR ANALYSIS

    5.1. Porter’s Five Forces Analysis

    5.1.1. Bargaining Power Of Suppliers

    5.1.2. Bargaining Power Of Buyers

    5.1.3. Threat Of New Entrants

    5.1.4. Threat Of Substitutes

    5.1.5. Intensity Of Rivalry

    5.2. Value Chain Analysis

    6. GLOBAL BONE BIOPSY MARKET, BY TYPE

    6.1. Overview

    6.2. Needle Biopsy

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    6.3. Open Biopsy

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7. GLOBAL BONE BIOPSY MARKET, BY GUIDANCE

    7.1. Overview

    7.2. Guided

    7.2.1. MRI Guided

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.2.2. CT Guided

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    7.3. Non-Guided

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    8. GLOBAL BONE BIOPSY MARKET, BY END USER

    8.1. Overview

    8.2. Hospitals & Clinics

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    8.3. Surgical Centers

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    8.4. Others

    Market Estimates & Forecast, By Region, 2020–2027

    Market Estimates & Forecast, By Country, 2020–2027

    9. GLOBAL BONE BIOPSY MARKET, BY REGION

    9.1. Overview

    9.2. Americas

    9.2.1. North America

    9.2.1.1. US

    9.2.1.2. Canada

    9.2.2. Latin America

    9.3. Europe

    9.3.1. Western Europe

    9.3.1.1. Germany

    9.3.1.2. France

    9.3.1.3. Italy

    9.3.1.4. Spain

    9.3.1.5. UK

    9.3.1.6. Rest Of Western Europe

    9.3.2. Eastern Europe

    9.4. Asia-Pacific

    9.4.1. Japan

    9.4.2. China

    9.4.3. India

    9.4.4. Australia

    9.4.5. South Korea

    9.4.6. Rest Of Asia-Pacific

    9.5. Middle East & Africa

    9.5.1. Middle East

    9.5.2. Africa

    10. COMPANY LANDSCAPE

    10.1.1. Overview

    10.1.2. Competitive Analysis

    11. COMPANY PROFILES

    11.1. BD

    11.1.1. Company Overview

    11.1.2. Product Type Overview

    11.1.3. Financial Overview

    11.1.4. Key Developments

    11.1.5. SWOT Analysis

    11.1.6. Key Strategies

    11.2. B. Braun Melsungen AG

    11.2.1. Company Overview

    11.2.2. Product Type Overview

    11.2.3. Financial Overview

    11.2.4. Key Developments

    11.2.5. SWOT Analysis

    11.2.6. Key Strategies

    11.3. Cook

    11.3.1. Company Overview

    11.3.2. Product Type Overview

    11.3.3. Financial Overview

    11.3.4. Key Developments

    11.3.5. SWOT Analysis

    11.3.6. Key Strategies

    11.4. GENERAL ELECTRIC COMPANY

    11.4.1. Company Overview

    11.4.2. Product Type Overview

    11.4.3. Financial Overview

    11.4.4. Key Developments

    11.4.5. SWOT Analysis

    11.4.6. Key Strategies

    11.5. ARGON MEDICAL

    11.5.1. Company Overview

    11.5.2. Product Type Overview

    11.5.3. Financial Overview

    11.5.4. Key Developments

    11.5.5. SWOT Analysis

    11.5.6. Key Strategies

    11.6. MERMAID MEDICAL A/S

    11.6.1. Company Overview

    11.6.2. Product Type Overview

    11.6.3. Financial Overview

    11.6.4. Key Developments

    11.6.5. SWOT Analysis

    11.6.6. Key Strategies

    11.7. Ranfac Corp.

    11.7.1. Company Overview

    11.7.2. Product Type Overview

    11.7.3. Financial Overview

    11.7.4. Key Developments

    11.7.5. SWOT Analysis

    11.7.6. Key Strategies

    11.8. Kimal

    11.8.1. Company Overview

    11.8.2. Product Type Overview

    11.8.3. Financial Overview

    11.8.4. Key Developments

    11.8.5. SWOT Analysis

    11.8.6. Key Strategies

    11.9. Remington Medical

    11.9.1. Company Overview

    11.9.2. Product Type Overview

    11.9.3. Financial Overview

    11.9.4. Key Developments

    11.9.5. SWOT Analysis

    11.9.6. Key Strategies

    11.10. Others

    11.10.1. Company Overview

    11.10.2. Product Type Overview

    11.10.3. Financial Overview

    11.10.4. Key Developments

    11.10.5. SWOT Analysis

    11.10.6. Key Strategies

    12. APPENDIX

    12.1. References

    12.2. Related Reports

    LIST OF TABLES

    TABLE 1 GLOBAL BONE BIOPSY MARKET SYNOPSIS, 2020–2027

    TABLE 2 GLOBAL BONE BIOPSY MARKET ESTIMATES & FORECAST, 2020–2027 (USD MILLION)

    TABLE 3 GLOBAL BONE BIOPSY MARKET, BY TYPE, 2020–2027 (USD MILLION)

    TABLE 4 GLOBAL BONE BIOPSY MARKET, BY GUIDANCE, 2020–2027 (USD MILLION)

    TABLE 5 GLOBAL BONE BIOPSY MARKET, BY END USER, 2020–2027 (USD MILLION)

    TABLE 6 GLOBAL BONE BIOPSY MARKET, BY REGION, 2020–2027 (USD MILLION)

    TABLE 7 NORTH AMERICA: BONE BIOPSY MARKET, BY TYPE, 2020–2027 (USD MILLION)

    TABLE 8 NORTH AMERICA: BONE BIOPSY MARKET, BY GUIDANCE, 2020–2027 (USD MILLION)

    TABLE 9 NORTH AMERICA: BONE BIOPSY MARKET, BY END USER, 2020–2027 (USD MILLION)

    TABLE 10 US: BONE BIOPSY MARKET, BY TYPE, 2020–2027 (USD MILLION)

    TABLE 11 US: BONE BIOPSY MARKET, BY GUIDANCE, 2020–2027 (USD MILLION)

    TABLE 12 US: BONE BIOPSY MARKET, BY END USER, 2020–2027 (USD MILLION)

    TABLE 13 CANADA: BONE BIOPSY MARKET, BY TYPE, 2020–2027 (USD MILLION)

    TABLE 14 CANADA: BONE BIOPSY MARKET, BY GUIDANCE, 2020–2027 (USD MILLION)

    TABLE 15 CANADA: BONE BIOPSY MARKET, BY END USER, 2020–2027 (USD MILLION)

    TABLE 16 LATIN AMERICA: BONE BIOPSY MARKET, BY TYPE, 2020–2027 (USD MILLION)

    TABLE 17 LATIN AMERICA: BONE BIOPSY MARKET, BY GUIDANCE, 2020–2027 (USD MILLION)

    TABLE 18 LATIN AMERICA: BONE BIOPSY MARKET, BY END USER, 2020–2027 (USD MILLION)

    TABLE 19 EUROPE: BONE BIOPSY MARKET, BY TYPE, 2020–2027 (USD MILLION)

    TABLE 20 EUROPE: BONE BIOPSY MARKET, BY GUIDANCE, 2020–2027 (USD MILLION)

    TABLE 21 EUROPE: BONE BIOPSY MARKET, BY END USER, 2020–2027 (USD MILLION)

    TABLE 22 WESTERN EUROPE: BONE BIOPSY MARKET, BY TYPE, 2020–2027 (USD MILLION)

    TABLE 23 WESTERN EUROPE: BONE BIOPSY MARKET, BY GUIDANCE, 2020–2027 (USD MILLION)

    TABLE 24 WESTERN EUROPE: BONE BIOPSY MARKET, BY END USER, 2020–2027 (USD MILLION)

    TABLE 25 EASTERN EUROPE: BONE BIOPSY MARKET, BY TYPE, 2020–2027 (USD MILLION)

    TABLE 26 EASTERN EUROPE: BONE BIOPSY MARKET, BY GUIDANCE, 2020–2027 (USD MILLION)

    TABLE 27 EASTERN EUROPE: BONE BIOPSY MARKET, BY END USER, 2020–2027 (USD MILLION)

    TABLE 28 ASIA-PACIFIC: BONE BIOPSY MARKET, BY TYPE, 2020–2027 (USD MILLION)

    TABLE 29 ASIA-PACIFIC: BONE BIOPSY MARKET, BY GUIDANCE, 2020–2027 (USD MILLION)

    TABLE 30 ASIA-PACIFIC: BONE BIOPSY MARKET, BY END USER, 2020–2027 (USD MILLION)

    TABLE 31 MIDDLE EAST & AFRICA: BONE BIOPSY MARKET, BY TYPE, 2020–2027 (USD MILLION)

    TABLE 32 MIDDLE EAST & AFRICA: BONE BIOPSY MARKET, BY GUIDANCE, 2020–2027 (USD MILLION)

    TABLE 33 MIDDLE EAST & AFRICA: BONE BIOPSY MARKET, BY END USER, 2020–2027 (USD MILLION)


    LIST OF FIGURES

    FIGURE 1 RESEARCH PROCESS

    FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL BONE BIOPSY MARKET

    FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL BONE BIOPSY MARKET

    FIGURE 4 GLOBAL BONE BIOPSY MARKET SHARE, BY TYPE, 2018 (%)

    FIGURE 5 GLOBAL BONE BIOPSY MARKET SHARE, BY GUIDANCE, 2018 (%)

    FIGURE 6 GLOBAL BONE BIOPSY MARKET SHARE, BY END USER, 2018 (%)

    FIGURE 7 GLOBAL BONE BIOPSY MARKET SHARE, BY REGION, 2018 (%)

    FIGURE 8 AMERICAS: BONE BIOPSY MARKET SHARE BY REGION, 2018 (%)

    FIGURE 9 NORTH AMERICA: BONE BIOPSY MARKET SHARE, BY COUNTRY, 2018 (%)

    FIGURE 10 EUROPE: BONE BIOPSY MARKET SHARE, BY REGION, 2018 (%)

    FIGURE 11 WESTERN EUROPE: BONE BIOPSY MARKET SHARE, BY COUNTRY, 2018 (%)

    FIGURE 12 ASIA-PACIFIC: BONE BIOPSY MARKET SHARE, BY COUNTRY, 2018 (%)

    FIGURE 13 MIDDLE EAST & AFRICA: BONE BIOPSY MARKET SHARE, BY COUNTRY, 2018 (%)

    FIGURE 14 GLOBAL BONE BIOPSY MARKET: COMPANY SHARE ANALYSIS, 2018 (%)

    FIGURE 15 BD: KEY FINANCIALS

    FIGURE 16 BD: SEGMENTAL REVENUE

    FIGURE 17 BD: REGIONAL REVENUE

    FIGURE 18 B. BRAUN MELSUNGEN AG: KEY FINANCIALS

    FIGURE 19 B. BRAUN MELSUNGEN AG: SEGMENTAL REVENUE

    FIGURE 20 B. BRAUN MELSUNGEN AG: REGIONAL REVENUE

    FIGURE 21 COOK: KEY FINANCIALS

    FIGURE 22 COOK: SEGMENTAL REVENUE

    FIGURE 23 COOK: REGIONAL REVENUE

    FIGURE 24 GENERAL ELECTRIC COMPANY: KEY FINANCIALS

    FIGURE 25 GENERAL ELECTRIC COMPANY: SEGMENTAL REVENUE

    FIGURE 26 GENERAL ELECTRIC COMPANY: REGIONAL REVENUE

    FIGURE 27 ARGON MEDICAL: KEY FINANCIALS

    FIGURE 28 ARGON MEDICAL: SEGMENTAL REVENUE

    FIGURE 29 ARGON MEDICAL: REGIONAL REVENUE

    FIGURE 30 MERMAID MEDICAL A/S: KEY FINANCIALS

    FIGURE 31 MERMAID MEDICAL A/S: SEGMENTAL REVENUE

    FIGURE 32 MERMAID MEDICAL A/S: REGIONAL REVENUE

    FIGURE 33 RANFAC CORP.: KEY FINANCIALS

    FIGURE 34 RANFAC CORP.: SEGMENTAL REVENUE

    FIGURE 35 RANFAC CORP.: REGIONAL REVENUE

    FIGURE 36 KIMAL: KEY FINANCIALS

    FIGURE 37 KIMAL: SEGMENTAL REVENUE

    FIGURE 38 KIMAL: REGIONAL REVENUE

    FIGURE 39 REMINGTON MEDICAL: KEY FINANCIALS

    FIGURE 40 REMINGTON MEDICAL: SEGMENTAL REVENUE

    FIGURE 41 REMINGTON MEDICAL: REGIONAL REVENUE